Extraventricular neurocytoma treated with 177Lu DOTATATE PRRT induction and maintenance therapies.

William Makis, Karey McCann, Alexander J B McEwan

Clinical nuclear medicine 2015 Mar

filter terms:

A 64-year-old woman with a 30-year history of recurrent sellar masses presented with severe headache and rapidly progressive visual field loss in the left eye. She was diagnosed with an extraventricular neurocytoma, which was octreotide positive, and was referred for PRRT (peptide receptor radionuclide therapy) with 177Lu [DOTA0,Tyr3]octreotate (DOTATATE). After 4 induction and 4 maintenance treatment cycles, her headaches resolved, her vision improved, and her sellar mass stabilized. The use of 177Lu DOTATATE PRRT in the management of extraventricular neurocytoma warrants further research.

Citation

William Makis, Karey McCann, Alexander J B McEwan. Extraventricular neurocytoma treated with 177Lu DOTATATE PRRT induction and maintenance therapies. Clinical nuclear medicine. 2015 Mar;40(3):234-6